BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38429664)

  • 21. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
    Tea F; Ospina Stella A; Aggarwal A; Ross Darley D; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Fichter C; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffmann M; Pöhlman S; Mazigi O; Christ D; Dwyer DE; Rockett RJ; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG
    PLoS Med; 2021 Jul; 18(7):e1003656. PubMed ID: 34228725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common variants at 21q22.3 locus influence
    Andolfo I; Russo R; Lasorsa VA; Cantalupo S; Rosato BE; Bonfiglio F; Frisso G; Abete P; Cassese GM; Servillo G; Esposito G; Gentile I; Piscopo C; Villani R; Fiorentino G; Cerino P; Buonerba C; Pierri B; Zollo M; Iolascon A; Capasso M
    iScience; 2021 Apr; 24(4):102322. PubMed ID: 33748697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
    Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
    Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genomic region associated with protection against severe COVID-19 is inherited from Neandertals.
    Zeberg H; Pääbo S
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33593941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-neutralizing antibodies predict disease severity and survival.
    Garcia-Beltran WF; Lam EC; Astudillo MG; Yang D; Miller TE; Feldman J; Hauser BM; Caradonna TM; Clayton KL; Nitido AD; Murali MR; Alter G; Charles RC; Dighe A; Branda JA; Lennerz JK; Lingwood D; Schmidt AG; Iafrate AJ; Balazs AB
    Cell; 2021 Jan; 184(2):476-488.e11. PubMed ID: 33412089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrelations between COVID-19 and other disorders.
    Gasmi A; Peana M; Pivina L; Srinath S; Gasmi Benahmed A; Semenova Y; Menzel A; Dadar M; Bjørklund G
    Clin Immunol; 2021 Mar; 224():108651. PubMed ID: 33333255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic mechanisms of critical illness in COVID-19.
    Pairo-Castineira E; Clohisey S; Klaric L; Bretherick AD; Rawlik K; Pasko D; Walker S; Parkinson N; Fourman MH; Russell CD; Furniss J; Richmond A; Gountouna E; Wrobel N; Harrison D; Wang B; Wu Y; Meynert A; Griffiths F; Oosthuyzen W; Kousathanas A; Moutsianas L; Yang Z; Zhai R; Zheng C; Grimes G; Beale R; Millar J; Shih B; Keating S; Zechner M; Haley C; Porteous DJ; Hayward C; Yang J; Knight J; Summers C; Shankar-Hari M; Klenerman P; Turtle L; Ho A; Moore SC; Hinds C; Horby P; Nichol A; Maslove D; Ling L; McAuley D; Montgomery H; Walsh T; Pereira AC; Renieri A; ; ; ; ; ; ; Shen X; Ponting CP; Fawkes A; Tenesa A; Caulfield M; Scott R; Rowan K; Murphy L; Openshaw PJM; Semple MG; Law A; Vitart V; Wilson JF; Baillie JK
    Nature; 2021 Mar; 591(7848):92-98. PubMed ID: 33307546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous variants that disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with speech/language delays and multiple congenital abnormalities.
    Snijders Blok L; Vino A; den Hoed J; Underhill HR; Monteil D; Li H; Reynoso Santos FJ; Chung WK; Amaral MD; Schnur RE; Santiago-Sim T; Si Y; Brunner HG; Kleefstra T; Fisher SE
    Genet Med; 2021 Mar; 23(3):534-542. PubMed ID: 33110267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Infection Boosts
    Bizzotto J; Sanchis P; Abbate M; Lage-Vickers S; Lavignolle R; Toro A; Olszevicki S; Sabater A; Cascardo F; Vazquez E; Cotignola J; Gueron G
    iScience; 2020 Oct; 23(10):101585. PubMed ID: 32989429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
    Zhang Q; Bastard P; Liu Z; Le Pen J; Moncada-Velez M; Chen J; Ogishi M; Sabli IKD; Hodeib S; Korol C; Rosain J; Bilguvar K; Ye J; Bolze A; Bigio B; Yang R; Arias AA; Zhou Q; Zhang Y; Onodi F; Korniotis S; Karpf L; Philippot Q; Chbihi M; Bonnet-Madin L; Dorgham K; Smith N; Schneider WM; Razooky BS; Hoffmann HH; Michailidis E; Moens L; Han JE; Lorenzo L; Bizien L; Meade P; Neehus AL; Ugurbil AC; Corneau A; Kerner G; Zhang P; Rapaport F; Seeleuthner Y; Manry J; Masson C; Schmitt Y; Schlüter A; Le Voyer T; Khan T; Li J; Fellay J; Roussel L; Shahrooei M; Alosaimi MF; Mansouri D; Al-Saud H; Al-Mulla F; Almourfi F; Al-Muhsen SZ; Alsohime F; Al Turki S; Hasanato R; van de Beek D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Imberti L; Sottini A; Paghera S; Quiros-Roldan E; Rossi C; Oler AJ; Tompkins MF; Alba C; Vandernoot I; Goffard JC; Smits G; Migeotte I; Haerynck F; Soler-Palacin P; Martin-Nalda A; Colobran R; Morange PE; Keles S; Çölkesen F; Ozcelik T; Yasar KK; Senoglu S; Karabela ŞN; Rodríguez-Gallego C; Novelli G; Hraiech S; Tandjaoui-Lambiotte Y; Duval X; Laouénan C; ; ; ; ; ; ; ; ; Snow AL; Dalgard CL; Milner JD; Vinh DC; Mogensen TH; Marr N; Spaan AN; Boisson B; Boisson-Dupuis S; Bustamante J; Puel A; Ciancanelli MJ; Meyts I; Maniatis T; Soumelis V; Amara A; Nussenzweig M; García-Sastre A; Krammer F; Pujol A; Duffy D; Lifton RP; Zhang SY; Gorochov G; Béziat V; Jouanguy E; Sancho-Shimizu V; Rice CM; Abel L; Notarangelo LD; Cobat A; Su HC; Casanova JL
    Science; 2020 Oct; 370(6515):. PubMed ID: 32972995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    ; Ellinghaus D; Degenhardt F; Bujanda L; Buti M; Albillos A; Invernizzi P; Fernández J; Prati D; Baselli G; Asselta R; Grimsrud MM; Milani C; Aziz F; Kässens J; May S; Wendorff M; Wienbrandt L; Uellendahl-Werth F; Zheng T; Yi X; de Pablo R; Chercoles AG; Palom A; Garcia-Fernandez AE; Rodriguez-Frias F; Zanella A; Bandera A; Protti A; Aghemo A; Lleo A; Biondi A; Caballero-Garralda A; Gori A; Tanck A; Carreras Nolla A; Latiano A; Fracanzani AL; Peschuck A; Julià A; Pesenti A; Voza A; Jiménez D; Mateos B; Nafria Jimenez B; Quereda C; Paccapelo C; Gassner C; Angelini C; Cea C; Solier A; Pestaña D; Muñiz-Diaz E; Sandoval E; Paraboschi EM; Navas E; García Sánchez F; Ceriotti F; Martinelli-Boneschi F; Peyvandi F; Blasi F; Téllez L; Blanco-Grau A; Hemmrich-Stanisak G; Grasselli G; Costantino G; Cardamone G; Foti G; Aneli S; Kurihara H; ElAbd H; My I; Galván-Femenia I; Martín J; Erdmann J; Ferrusquía-Acosta J; Garcia-Etxebarria K; Izquierdo-Sanchez L; Bettini LR; Sumoy L; Terranova L; Moreira L; Santoro L; Scudeller L; Mesonero F; Roade L; Rühlemann MC; Schaefer M; Carrabba M; Riveiro-Barciela M; Figuera Basso ME; Valsecchi MG; Hernandez-Tejero M; Acosta-Herrera M; D'Angiò M; Baldini M; Cazzaniga M; Schulzky M; Cecconi M; Wittig M; Ciccarelli M; Rodríguez-Gandía M; Bocciolone M; Miozzo M; Montano N; Braun N; Sacchi N; Martínez N; Özer O; Palmieri O; Faverio P; Preatoni P; Bonfanti P; Omodei P; Tentorio P; Castro P; Rodrigues PM; Blandino Ortiz A; de Cid R; Ferrer R; Gualtierotti R; Nieto R; Goerg S; Badalamenti S; Marsal S; Matullo G; Pelusi S; Juzenas S; Aliberti S; Monzani V; Moreno V; Wesse T; Lenz TL; Pumarola T; Rimoldi V; Bosari S; Albrecht W; Peter W; Romero-Gómez M; D'Amato M; Duga S; Banales JM; Hov JR; Folseraas T; Valenti L; Franke A; Karlsen TH
    N Engl J Med; 2020 Oct; 383(16):1522-1534. PubMed ID: 32558485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considering how biological sex impacts immune responses and COVID-19 outcomes.
    Scully EP; Haverfield J; Ursin RL; Tannenbaum C; Klein SL
    Nat Rev Immunol; 2020 Jul; 20(7):442-447. PubMed ID: 32528136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7).
    Chin Med J (Engl); 2020 May; 133(9):1087-1095. PubMed ID: 32358325
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
    Wu Z; McGoogan JM
    JAMA; 2020 Apr; 323(13):1239-1242. PubMed ID: 32091533
    [No Abstract]   [Full Text] [Related]  

  • 37. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.
    Wu X; Xiao Y; Zhou Y; Zhou Z; Yan W
    Cell Death Dis; 2019 Jun; 10(7):472. PubMed ID: 31209207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decoding type I and III interferon signalling during viral infection.
    Mesev EV; LeDesma RA; Ploss A
    Nat Microbiol; 2019 Jun; 4(6):914-924. PubMed ID: 30936491
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Souyris M; Cenac C; Azar P; Daviaud D; Canivet A; Grunenwald S; Pienkowski C; Chaumeil J; Mejía JE; Guéry JC
    Sci Immunol; 2018 Jan; 3(19):. PubMed ID: 29374079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity.
    Graf L; Dick A; Sendker F; Barth E; Marz M; Daumke O; Kochs G
    J Biol Chem; 2018 Mar; 293(9):3056-3072. PubMed ID: 29330299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.